Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

IDEA licenses drug delivery technology to Procter & Gamble

Oct. 28, 1998

CE Mark approval granted for AastromReplicell system components

Oct. 28, 1998

Baxter, Inhale will seek partner to continue development of drug candidate

Oct. 28, 1998

ThromboSol prolongs cryopreservation of rhTPO-stimulated platelets in in vitro study

Oct. 27, 1998

Phase I studies establish feasibility, tolerability of oral delivery of heparin

Oct. 26, 1998

Endorex/Elan joint venture to develop Medipad-based drugs

Oct. 26, 1998

First high-affinity, nonpeptide BB1, BB2 receptor antagonists designed at Parke-Davis

Oct. 26, 1998

Millennium BioTherapeutics to use Abgenix human antibody technology

Oct. 21, 1998

Aradigm licenses new aerosol technology from Spanish university

Oct. 21, 1998

Clinical trial results reported, development plans outlined for Aastrom stem cell therapy system

Oct. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...